
到 2027 年亚太地区智能吸入器市场 - 按产品(雾化器和吸入器)进行区域分析和预测;疾病(慢性阻塞性肺病(COPD)和哮喘);最终用户(家庭护理机构以及医院和诊所)和国家/地区
No. of Pages: 108 | Report Code: TIPRE00007070 | Category: Life Sciences
No. of Pages: 108 | Report Code: TIPRE00007070 | Category: Life Sciences
亚太地区智能吸入器市场预计将从 2018 年的 1.8663 亿美元增至 2027 年的 15.3997 亿美元。预计从 2019 年开始,该市场将以 27.2% 的复合年增长率增长-2027年。
市场的增长是由以下因素驱动的: 老年人口的增长、慢性阻塞性肺病和哮喘的患病率上升,以及人们对健康状况的认识不断提高。然而,由于与网络威胁相关的风险,有关智能吸入器使用的知识有限,市场可能会受到影响。
< p>随着城市化的快速发展,各种不利因素不断增加,导致整个亚太地区呼吸系统疾病的增加。导致亚太地区哮喘和慢性阻塞性肺病病例数量增加的一些因素是空气污染水平的上升和吸烟习惯的增加。
空气污染水平的上升一直是发达国家和发展中经济体日益关注的问题。根据世界卫生组织 (WHO) 2018 年 5 月发布的数据,据信每 10 人中有 9 人呼吸含有高浓度污染物的空气。世界卫生组织公布的数据显示,每年约有 700 万人因接触污染空气中的细颗粒而死亡,这些颗粒深入肺部和心血管系统。这会导致多种疾病,如肺癌、肺炎、慢性阻塞性肺病和呼吸道感染等。 2016年,亚太地区因空气污染而死亡的220万人中,29%死于心脏病,27%死于中风,22%死于慢性阻塞性肺病,14%死于肺癌,8%死于肺炎。此外,空气污染的间接影响日益增加,例如日益严重的气候变化,因为交通运输是化石燃料二氧化碳 (CO2) 排放增长最快的来源,而二氧化碳 (CO2) 是气候变化的最大贡献者。 2017年,世界卫生组织(WHO)就解决西太平洋地区空气污染对健康的影响举行了成员国磋商,并继续采取措施改善这一状况。居住在重型车辆交通繁忙的道路附近的儿童患呼吸系统疾病的风险是居住在交通不太拥堵的街道附近的儿童的两倍。因此,空气污染水平的上升预计将在预测期内推动智能吸入器市场的需求
2018年,按产品划分,吸入器细分市场在智能吸入器市场中占有最大的市场份额。由于哮喘死亡率不断上升,预计吸入器将在 2027 年占据市场份额。预计吸入器细分市场在 2019 年至 2027 年的预测期内也将出现最快的增长率。
由于全国范围内哮喘和慢性阻塞性肺病的患病率不断上升,预计中国将引领亚太地区的市场。据《柳叶刀》最近发表的报告显示,中国约1亿成年人口中约有9%患有慢性阻塞性肺病(COPD)。因此,考虑到上述因素,在预测期内,该国市场的增长可能会在亚太地区贡献最大份额。
图表:亚太地区其他地区智能吸入器市场收入和预测至 2027 年(百万美元)
p>
亚太地区智能吸入器–市场细分
按产品强>
按无序
最终用户
按地理位置
公司简介
Strategic insights for Asia Pacific Smart Inhalers involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2018 | US$ 186.63 Million |
Market Size by 2027 | US$ 1,539.97 Million |
Global CAGR (2019 - 2027) | 27.2% |
Historical Data | 2016-2017 |
Forecast period | 2019-2027 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Smart Inhalers refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies
The Asia Pacific Smart Inhalers Market is valued at US$ 186.63 Million in 2018, it is projected to reach US$ 1,539.97 Million by 2027.
As per our report Asia Pacific Smart Inhalers Market, the market size is valued at US$ 186.63 Million in 2018, projecting it to reach US$ 1,539.97 Million by 2027. This translates to a CAGR of approximately 27.2% during the forecast period.
The Asia Pacific Smart Inhalers Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Smart Inhalers Market report:
The Asia Pacific Smart Inhalers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Smart Inhalers Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Smart Inhalers Market value chain can benefit from the information contained in a comprehensive market report.